Literature DB >> 19819883

Endocannabinoid signalling as an anti-inflammatory therapeutic target in atherosclerosis: does it work?

Stephan Immenschuh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19819883     DOI: 10.1093/cvr/cvp339

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


× No keyword cloud information.
  3 in total

1.  Inactivation of lipid glyceryl ester metabolism in human THP1 monocytes/macrophages by activated organophosphorus insecticides: role of carboxylesterases 1 and 2.

Authors:  Shuqi Xie; Abdolsamad Borazjani; M Jason Hatfield; Carol C Edwards; Philip M Potter; Matthew K Ross
Journal:  Chem Res Toxicol       Date:  2010-12-20       Impact factor: 3.739

Review 2.  Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress.

Authors:  George W Booz
Journal:  Free Radic Biol Med       Date:  2011-01-14       Impact factor: 7.376

3.  Cannabinoid receptor 2 activation alleviates diabetes-induced cardiac dysfunction, inflammation, oxidative stress, and fibrosis.

Authors:  Mohanraj Rajesh; Partha Mukhopadhyay; Sándor Bátkai; Muhammad Arif; Zoltán V Varga; Csaba Mátyás; Janos Paloczi; Andrea Lehocki; György Haskó; Pal Pacher
Journal:  Geroscience       Date:  2022-04-22       Impact factor: 7.581

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.